← Open Payments lookup

FLORENCE NWANA: Open Payments

NPI 1023443652 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,764 in 87 payments from 14 companies in 2025. Trend: 2023 $1,480 · 2024 $1,414 · 2025 $2,764

Food & beverage: $2,744Education: $20
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)26$753
ABBVIE INC.12$440
Vanda Pharmaceuticals Inc.13$383
Neurocrine BioSciences, Inc.5$319
Otsuka America Pharmaceutical, Inc.8$227
Axsome Therapeutics, Inc.5$186
Janssen Pharmaceuticals, Inc2$123
Lundbeck LLC4$90
Bausch Health US, LLC4$70
Alkermes, Inc.3$60

Products named: CAPLYTA, VRAYLAR, FANAPT, INGREZZA, Auvelity, REXULTI, INVEGA SUSTENNA, ABILIFY MAINTENA.

Industry payments across MD — which companies pay providers there.